Abiopharma

🔍 Chen Jingye (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 1,866 shares of Class A ordinary shares at $85.74 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 9,075,774.00 | transaction_form_type: 4
• Sold 551 shares of Class A ordinary shares at $82.2 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 232,249.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 204 shares of Class A ordinary shares at $83.51 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 232,045.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 45 shares of Class A ordinary shares at $84.4 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 232,000.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on August 28, 2025.
• F2: Represents the weighted average price of shares sold at prices that ranged from $81.93 to $82.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $82.99 to $83.92.
• F4: Represents the weighted average price of shares sold at prices that ranged from $83.93 to $84.79.